Investments
67Portfolio Exits
11Funds
7
Want to inform investors similar to Catalyst Health Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Research containing Catalyst Health Ventures
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Catalyst Health Ventures in 1 CB Insights research brief, most recently on May 12, 2021.
Latest Catalyst Health Ventures News
Dec 13, 2022
Medtech company Rejoni has raised $25M in Series B funding from Catalyst Health Ventures. Other investors in the round include Ascension Health Ventures, Delos Capital, Sparta Group, Amed Ventures, and Iyengar Capital Partners. Rejoni raised its $15M Series A in September 2020. Rejoni is a privately held medical technology company designing and developing hydrogels to improve the standard of care in Women’s Health. Rejoni’s…
Catalyst Health Ventures Investments
67 Investments
Catalyst Health Ventures has made 67 investments. Their latest investment was in PanTher Therapeutics as part of their Series B on December 12, 2022.
Catalyst Health Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/19/2022 | Series B | PanTher Therapeutics | $1.26M | No | Catalyst Health Ventures, and Undisclosed Investors | 1 |
12/7/2022 | Series B | Rejoni | $25M | Yes | 6 | |
7/18/2022 | Unattributed VC | Aria CV | $7.77M | No | 1 | |
3/11/2022 | Series A | |||||
2/17/2022 | Series B |
Date | 12/19/2022 | 12/7/2022 | 7/18/2022 | 3/11/2022 | 2/17/2022 |
|---|---|---|---|---|---|
Round | Series B | Series B | Unattributed VC | Series A | Series B |
Company | PanTher Therapeutics | Rejoni | Aria CV | ||
Amount | $1.26M | $25M | $7.77M | ||
New? | No | Yes | No | ||
Co-Investors | Catalyst Health Ventures, and Undisclosed Investors | ||||
Sources | 1 | 6 | 1 |
Catalyst Health Ventures Portfolio Exits
11 Portfolio Exits
Catalyst Health Ventures has 11 portfolio exits. Their latest portfolio exit was Sera Prognostics on July 16, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/16/2021 | IPO | Public | 1 | ||
9/3/2020 | Acquired | 12 | |||
9/6/2018 | Acquired | 5 | |||
Date | 7/16/2021 | 9/3/2020 | 9/6/2018 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 1 | 12 | 5 |
Catalyst Health Ventures Fund History
7 Fund Histories
Catalyst Health Ventures has 7 funds, including CHV SPV I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/22/2020 | CHV SPV I | $1.05M | 1 | ||
12/18/2020 | Catalyst Health Ventures IV | ||||
12/18/2020 | CHV Partners Fund IV | ||||
7/18/2016 | Catalyst Health Ventures Follow-On Fund | ||||
12/31/2012 | Catalyst Health Ventures III LP |
Closing Date | 12/22/2020 | 12/18/2020 | 12/18/2020 | 7/18/2016 | 12/31/2012 |
|---|---|---|---|---|---|
Fund | CHV SPV I | Catalyst Health Ventures IV | CHV Partners Fund IV | Catalyst Health Ventures Follow-On Fund | Catalyst Health Ventures III LP |
Fund Type | |||||
Status | |||||
Amount | $1.05M | ||||
Sources | 1 |
Catalyst Health Ventures Team
5 Team Members
Catalyst Health Ventures has 5 team members, including current Chief Executive Officer, Nick Kimball.
Name | Work History | Title | Status |
|---|---|---|---|
Nick Kimball | Chief Executive Officer | Current | |
Name | Nick Kimball | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.